Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katarzyna Kolasa

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|May 1, 2018
How can multi criteria decision analysis support value assessment of pharmaceuticals? - Findings from a systematic literature reviewKatarzyna Kolasa, Vladimir Zah, Marta Kowalczyk
Przeglad Epidemiologiczny|June 27, 2016
Health technology assessment of public health programmes in Poland, years 2010 and 2013Katarzyna Kolasa, Agnieszka Turlej, Tomasz Hermanowski
Przeglad Epidemiologiczny|April 19, 2014
Importance of public participation in decision-making process in healthcare system illustarted with an example of the development of American and Polish scope of health benefit basketKatarzyna Kolasa, Tomasz Hermanowski, Ewa Borek
International Journal of Technology Assessment in Health Care|January 26, 2011
What aspects of the health technology assessment process recommended by international health technology assessment agencies received the most attention in Poland in 2008?Katarzyna Kolasa, Malgorzata Dziomdziora, Liberty Fajutrao
Expert Review of Pharmacoeconomics & Outcomes Research|June 27, 2014
Pricing and reimbursement frameworks in Central Eastern Europe: a decision tool to support choicesKatarzyna Kolasa, Zoltan Kalo, Edward Hornby
Expert Review of Pharmacoeconomics & Outcomes Research|July 29, 2016
The use of non-economic criteria in pricing and reimbursement decisions in Central and Eastern Europe: issues, trends and recommendationsKatarzyna Kolasa, Zoltan Kalo, Vladimir Zah
Expert Review of Pharmacoeconomics & Outcomes Research|April 7, 2020
'Without data, you're just another person with an opinion'Katarzyna Kolasa, Wim Goettsch, Guenka Petrova, et al.
Health Policy (Amsterdam, Netherlands)|June 7, 2011
A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policymaking processes in PolandKatarzyna Kolasa, Sebastian Schubert, Andrea Manca, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 21, 2012
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countriesKatarzyna Kolasa, Zoltan Kalo, Vladimir Zah, et al.
Computers in Biology and Medicine|July 22, 2025
Comprehensive analysis of frameworks for evaluating artificial intelligence solutions in Healthcare: A descriptive reviewNikola Fajkis-Zajączkowska, Anna Zawada, Magdalena Bojko, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Expert Review of Pharmacoeconomics & Outcomes Research|May 1, 2018
How can multi criteria decision analysis support value assessment of pharmaceuticals? - Findings from a systematic literature reviewKatarzyna Kolasa, Vladimir Zah, Marta Kowalczyk
Przeglad Epidemiologiczny|June 27, 2016
Health technology assessment of public health programmes in Poland, years 2010 and 2013Katarzyna Kolasa, Agnieszka Turlej, Tomasz Hermanowski
Przeglad Epidemiologiczny|April 19, 2014
Importance of public participation in decision-making process in healthcare system illustarted with an example of the development of American and Polish scope of health benefit basketKatarzyna Kolasa, Tomasz Hermanowski, Ewa Borek
International Journal of Technology Assessment in Health Care|January 26, 2011
What aspects of the health technology assessment process recommended by international health technology assessment agencies received the most attention in Poland in 2008?Katarzyna Kolasa, Malgorzata Dziomdziora, Liberty Fajutrao
Expert Review of Pharmacoeconomics & Outcomes Research|June 27, 2014
Pricing and reimbursement frameworks in Central Eastern Europe: a decision tool to support choicesKatarzyna Kolasa, Zoltan Kalo, Edward Hornby
Expert Review of Pharmacoeconomics & Outcomes Research|July 29, 2016
The use of non-economic criteria in pricing and reimbursement decisions in Central and Eastern Europe: issues, trends and recommendationsKatarzyna Kolasa, Zoltan Kalo, Vladimir Zah
Expert Review of Pharmacoeconomics & Outcomes Research|April 7, 2020
'Without data, you're just another person with an opinion'Katarzyna Kolasa, Wim Goettsch, Guenka Petrova, et al.
Health Policy (Amsterdam, Netherlands)|June 7, 2011
A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policymaking processes in PolandKatarzyna Kolasa, Sebastian Schubert, Andrea Manca, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 21, 2012
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countriesKatarzyna Kolasa, Zoltan Kalo, Vladimir Zah, et al.
Computers in Biology and Medicine|July 22, 2025
Comprehensive analysis of frameworks for evaluating artificial intelligence solutions in Healthcare: A descriptive reviewNikola Fajkis-Zajączkowska, Anna Zawada, Magdalena Bojko, et al.
Pageof 5